Journal of Clinical Endocrinology & Metabolism, Vol 81, 2768-2772, Copyright © 1996 by Endocrine Society

ARTICLES

Prevalence and mechanisms of hearing loss in patients with resistance to thyroid hormone

F Brucker-Davis, MC Skarulis, A Pikus, D Ishizawar, MA Mastroianni, M Koby and BD Weintraub
Molecular and Cellular Endocrinology Branch, National Institute of Diabetes, Digestive, and Kidney Disease, National Institutes of Health, Bethesda, Maryland 20892-1758, USA.

Hearing impairment was anecdotally reported in resistance to thyroid hormone (RTH), a condition caused by mutations in the beta-thyroid hormone receptor (beta TR) gene. Because of its ontogenic distribution in the cochlea, the beta TR may have a pivotal role in the development of auditory function. To assess the prevalence and mechanisms of hearing impairment in RTH, 82 RTH-positive (RTH+) patients and 55 unaffected relatives (RTH-) underwent systematic audiological examination, including puretone and speech reception thresholds, and tests studying middle ear (tympanometry and acoustic reflexes), cochlear (otoacoustic emissions), and retrocochlear integrity (brain stem auditory evoked potentials). Significant hearing loss was present in 21% of RTH+ patients vs. none in RTH- patients. More RTH+ patients had abnormal tympanometry (34% vs. 12%) and abnormal acoustic reflexes (39% vs. 19%). Isolated conductive deficit was found in 7 of 17 RTH+ patients with hearing loss, isolated sensorineural deficit in 7 cases, and mixed deficit in 3 cases. Cochlear dysfunction was found in 50% of all RTH+ patients, with or without hearing loss. Retrocochlear function was normal. No morphological cochlear abnormalities were detected on computed tomography of the temporal bone. In conclusion, hearing loss is a significant problem in RTH, with an equal frequency of conductive (probably related to the frequent ear infections) and sensorineural deficits. Abnormal otoacoustic emissions suggest that the mutant beta TR has a specific negative impact on cochlear function.

This article has been cited by other articles:

				E. E. Wasserman, K. Nelson, N. R. Rose, W. Eaton, J. P. Pillion, E. Seaberg, M. V. Talor, L. Burek, A. Duggan, and R. H. Yolken Maternal Thyroid Autoantibodies during the Third Trimester and Hearing Deficits in Children: An Epidemiologic Assessment Am. J. Epidemiol., March 15, 2008; 167(6): 701 - 710. [Abstract] [Full Text] [PDF]

				N. Brandt, S. Kuhn, S. Munkner, C. Braig, H. Winter, N. Blin, R. Vonthein, M. Knipper, and J. Engel Thyroid Hormone Deficiency Affects Postnatal Spiking Activity and Expression of Ca2+ and K+ Channels in Rodent Inner Hair Cells J. Neurosci., March 21, 2007; 27(12): 3174 - 3186. [Abstract] [Full Text] [PDF]

				L. Ng, R. J. Goodyear, C. A. Woods, M. J. Schneider, E. Diamond, G. P. Richardson, M. W. Kelley, D. L. St. Germain, V. A. Galton, and D. Forrest Hearing loss and retarded cochlear development in mice lacking type 2 iodothyronine deiodinase PNAS, March 9, 2004; 101(10): 3474 - 3479. [Abstract] [Full Text] [PDF]

				A. Rusch, L. Ng, R. Goodyear, D. Oliver, I. Lisoukov, B. Vennstrom, G. Richardson, M. W. Kelley, and D. Forrest Retardation of Cochlear Maturation and Impaired Hair Cell Function Caused by Deletion of All Known Thyroid Hormone Receptors J. Neurosci., December 15, 2001; 21(24): 9792 - 9800. [Abstract] [Full Text] [PDF]

				L. Ng, A. Rusch, L. L. Amma, K. Nordstrom, L. C. Erway, B. Vennstrom, and D. Forrest Suppression of the deafness and thyroid dysfunction in Thrb-null mice by an independent mutation in the Thra thyroid hormone receptor {alpha} gene Hum. Mol. Genet., November 1, 2001; 10(23): 2701 - 2708. [Abstract] [Full Text] [PDF]

				S. A. Phillips, P. Rotman-Pikielny, J. Lazar, S. Ando, P. Hauser, M. C. Skarulis, F. Brucker-Davis, and P. M. Yen Extreme Thyroid Hormone Resistance in a Patient with a Novel Truncated TR Mutant J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5142 - 5147. [Abstract] [Full Text] [PDF]

				A. Campos-Barros, L. L. Amma, J. S. Faris, R. Shailam, M. W. Kelley, and D. Forrest Type 2 iodothyronine deiodinase expression in the cochlea before the onset of hearing PNAS, February 1, 2000; 97(3): 1287 - 1292. [Abstract] [Full Text] [PDF]

				R. E. Weiss and S. Refetoff Editorial: Treatment of Resistance to Thyroid Hormone--Primum Non Nocere J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 401 - 404. [Full Text]

				A. Rusch, L. C. Erway, D. Oliver, B. Vennstrom, and D. Forrest Thyroid hormone receptor beta -dependent expression of a potassium conductance in inner hair cells at the onset of hearing PNAS, December 22, 1998; 95(26): 15758 - 15762. [Abstract] [Full Text] [PDF]